标普生物科技LOF(161127)
动态评分： 5.92分
投资组合
| 报告日期 | 代码 | 名称 | 金额(万元) | 比例 |
| 2022-03-31 | EDIT | Editas Medicine Inc | 215.07 | 1.02% |
| 2022-03-31 | MRNA | Moderna Inc | 212.26 | 1.01% |
| 2022-03-31 | GBT | 全球血液疗法 | 212.12 | 1.01% |
| 2022-03-31 | KRTX | Karuna Therapeutics Inc | 209.83 | 0.99% |
| 2022-03-31 | CDNA | CareDx Inc | 204.65 | 0.97% |
| 2022-03-31 | ARCT | Arcturus Therapeutics Holdings Inc | 203.84 | 0.97% |
| 2022-03-31 | NTLA | Intellia Therapeutics Inc | 201.92 | 0.96% |
| 2022-03-31 | BBIO | BridgeBio Pharma Inc | 201.45 | 0.96% |
| 2021-12-31 | ARNA | Arena Pharmaceuticals Inc | 205.8 | 1.36% |
| 2021-12-31 | BHVN | Biohaven Pharmaceutical Holding Co Ltd | 152.79 | 1.01% |
| 2021-12-31 | CYTK | Cytokinetics Inc | 139.61 | 0.92% |
| 2021-12-31 | TPTX | Turning Point Therapeutics Inc | 132.78 | 0.88% |
| 2021-12-31 | BCRX | BioCryst Pharmaceuticals Inc | 131.44 | 0.87% |
| 2021-12-31 | FATE | Fate Therapeutics Inc | 131.61 | 0.87% |
| 2021-12-31 | HALO | 奥洛兹美医疗 | 128.88 | 0.85% |
| 2021-12-31 | TGTX | TG Therapeutics Inc | 126.78 | 0.84% |
| 2021-12-31 | UTHR | 联合治疗 | 126.74 | 0.84% |
| 2021-12-31 | ISEE | IVERIC bio Inc | 126.09 | 0.83% |
| 2021-12-31 | INCY | 因塞特医疗 | 124.11 | 0.82% |
| 2021-12-31 | APLS | Apellis Pharmaceuticals Inc | 124.83 | 0.82% |
公告&资料
